N-[1-[2-(dimethylamino)ethyl]benzimidazol-5-yl]-2-(2,5-dioxo-3,4-dihydro-1H-1,4-benzodiazepin-3-yl)acetamide

C22H24N6O3 — CID 122169438

IUPACN-[1-[2-(dimethylamino)ethyl]benzimidazol-5-yl]-2-(2,5-dioxo-3,4-dihydro-1H-1,4-benzodiazepin-3-yl)acetamide
SMILESCN(C)CCn1cnc2cc(NC(=O)CC3NC(=O)c4ccccc4NC3=O)ccc21
InChIInChI=1S/C22H24N6O3/c1-27(2)9-10-28-13-23-17-11-14(7-8-19(17)28)24-20(29)12-18-22(31)25-16-6-4-3-5-15(16)21(30)26-18/h3-8,11,13,18H,9-10,12H2,1-2H3,(H,24,29)(H,25,31)(H,26,30)
InChIKeyRSTYGXDUMYJSLV-UHFFFAOYSA-N
MW420.47 g/mol
LogP1.68
Rot. Bonds6

About N-[1-[2-(dimethylamino)ethyl]benzimidazol-5-yl]-2-(2,5-dioxo-3,4-dihydro-1H-1,4-benzodiazepin-3-yl)acetamide

N-[1-[2-(dimethylamino)ethyl]benzimidazol-5-yl]-2-(2,5-dioxo-3,4-dihydro-1H-1,4-benzodiazepin-3-yl)acetamide (PubChem CID 122169438) has the molecular formula C22H24N6O3 and a molecular weight of 420.47 g/mol. Its IUPAC name is N-[1-[2-(dimethylamino)ethyl]benzimidazol-5-yl]-2-(2,5-dioxo-3,4-dihydro-1H-1,4-benzodiazepin-3-yl)acetamide.

Molecular Properties

Compound NameN-[1-[2-(dimethylamino)ethyl]benzimidazol-5-yl]-2-(2,5-dioxo-3,4-dihydro-1H-1,4-benzodiazepin-3-yl)acetamide
PubChem CID122169438
Molecular FormulaC22H24N6O3
Molecular Weight420.47 g/mol
Exact Mass420.19
IUPAC NameN-[1-[2-(dimethylamino)ethyl]benzimidazol-5-yl]-2-(2,5-dioxo-3,4-dihydro-1H-1,4-benzodiazepin-3-yl)acetamide
SMILESCN(C)CCn1cnc2cc(NC(=O)CC3NC(=O)c4ccccc4NC3=O)ccc21
InChIInChI=1S/C22H24N6O3/c1-27(2)9-10-28-13-23-17-11-14(7-8-19(17)28)24-20(29)12-18-22(31)25-16-6-4-3-5-15(16)21(30)26-18/h3-8,11,13,18H,9-10,12H2,1-2H3,(H,24,29)(H,25,31)(H,26,30)
InChIKeyRSTYGXDUMYJSLV-UHFFFAOYSA-N
XLogP1.68
TPSA108.36 Ų
H-Bond Donors3
H-Bond Acceptors6
Rotatable Bonds6
Heavy Atoms31
Complexity

Lipinski Rule of Five

Passes Rule of Five

RuleValue
MW ≤ 500420.47
LogP ≤ 51.68
H-Bond Donors ≤ 53
H-Bond Acceptors ≤ 106

Analyze N-[1-[2-(dimethylamino)ethyl]benzimidazol-5-yl]-2-(2,5-dioxo-3,4-dihydro-1H-1,4-benzodiazepin-3-yl)acetamide with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Frequently Asked Questions

What is the IUPAC name of N-[1-[2-(dimethylamino)ethyl]benzimidazol-5-yl]-2-(2,5-dioxo-3,4-dihydro-1H-1,4-benzodiazepin-3-yl)acetamide?
The IUPAC name of N-[1-[2-(dimethylamino)ethyl]benzimidazol-5-yl]-2-(2,5-dioxo-3,4-dihydro-1H-1,4-benzodiazepin-3-yl)acetamide (CID 122169438) is N-[1-[2-(dimethylamino)ethyl]benzimidazol-5-yl]-2-(2,5-dioxo-3,4-dihydro-1H-1,4-benzodiazepin-3-yl)acetamide.
What is the SMILES notation for N-[1-[2-(dimethylamino)ethyl]benzimidazol-5-yl]-2-(2,5-dioxo-3,4-dihydro-1H-1,4-benzodiazepin-3-yl)acetamide?
The canonical SMILES for N-[1-[2-(dimethylamino)ethyl]benzimidazol-5-yl]-2-(2,5-dioxo-3,4-dihydro-1H-1,4-benzodiazepin-3-yl)acetamide is CN(C)CCn1cnc2cc(NC(=O)CC3NC(=O)c4ccccc4NC3=O)ccc21.
What is the InChIKey of N-[1-[2-(dimethylamino)ethyl]benzimidazol-5-yl]-2-(2,5-dioxo-3,4-dihydro-1H-1,4-benzodiazepin-3-yl)acetamide?
The InChIKey is RSTYGXDUMYJSLV-UHFFFAOYSA-N. The full InChI is InChI=1S/C22H24N6O3/c1-27(2)9-10-28-13-23-17-11-14(7-8-19(17)28)24-20(29)12-18-22(31)25-16-6-4-3-5-15(16)21(30)26-18/h3-8,11,13,18H,9-10,12H2,1-2H3,(H,24,29)(H,25,31)(H,26,30).
What are the key properties of N-[1-[2-(dimethylamino)ethyl]benzimidazol-5-yl]-2-(2,5-dioxo-3,4-dihydro-1H-1,4-benzodiazepin-3-yl)acetamide?
N-[1-[2-(dimethylamino)ethyl]benzimidazol-5-yl]-2-(2,5-dioxo-3,4-dihydro-1H-1,4-benzodiazepin-3-yl)acetamide has a molecular weight of 420.47 g/mol, XLogP of 1.68, 6 rotatable bonds, 3 hydrogen bond donors, and 6 hydrogen bond acceptors.
Where does this data come from?
All data for N-[1-[2-(dimethylamino)ethyl]benzimidazol-5-yl]-2-(2,5-dioxo-3,4-dihydro-1H-1,4-benzodiazepin-3-yl)acetamide is sourced from PubChem (CID 122169438), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).